Unknown NA INTERVENTIONAL 2-arm NCT03668171

Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure

Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure, a Randomized, Double Blind, Placebo Controlled Trial

Sponsor: Xijing Hospital of Digestive Diseases

Conditions Acute-On-Chronic Liver Failure

Interventions mesenchymal stem cell transplantation or placebo infusion via peripheral vein

Updated 5 times since 2018 Last updated: Sep 10, 2018 Started: Dec 10, 2017 Primary completion: Dec 31, 2019 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03668171, this NA trial focuses on Acute-On-Chronic Liver Failure and remains ongoing. Sponsored by Xijing Hospital of Digestive Diseases, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Oct 2018 — Jan 2021 [monthly]

Recruiting NA

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xijing Hospital of Digestive Diseases

Data source: Xijing Hospital of Digestive Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China